SERPINB5 and cancer: Accordingly, clinical studies observed that maspin localization in the nucleus correlates with favorable prognosis in different cancer types [8, 11, 12], whereas cytoplasmic-only or cytoplasmic and nuclear localization correlate with poor prognosis [13–15].